2113-P: Beyond Race and Ethnicity in Pediatric Diabetes: Genetic Ancestry and Social Determinants of Health in Diabetic Ketoacidosis
Diabetes · 05.06.2026 · 75 (Supplement_1)
DOI: 10.2337/db26-2113-p ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes, erschienen am 05.06.2026. Verfasst von KATHRYN JONES und 11 weiteren Autor:innen.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Introduction and Objective: Diabetic ketoacidosis (DKA) is a major cause of morbidity in pediatric diabetes, with marked variation by race and ethnicity. However, race and ethnicity may not fully capture the biological and social determinants of health (SDoH) driving DKA risk. We studied whether post-diagnosis DKA reflects SDOH, genetic ancestry or both in diverse youth.
Methods
We conducted a secondary analysis of a pediatric diabetes cohort (3-10 years’ duration; self-identified non-Hispanic Black [NHB] 28%, Hispanic/Latino [HS] 38% and non-Hispanic White [NHW] 25%). Social vulnerability indices were derived from American Community Survey data. Those with and without post-diagnosis DKA were compared with Chi-square, Wilcoxon rank-sum, or Fisher exact tests, and multivariable logistic regression identified DKA predictors.
Results
Post-diagnosis DKA occurred in 38% of HS youth and 36% of NHB youth, compared with 10% of NHW youth. In multivariable logistic regression, genetic ancestry and SDoH were independently associated with DKA. African genetic ancestry and greater neighborhood poverty were significantly associated with increased odds of DKA (Table).
Conclusion
Pediatric DKA risk reflects the joint influence of genetic ancestry and socioeconomic factors, supporting approaches that move beyond race/ethnicity to directly assess biological and social contributors to diabetic complications. Disclosure K. Jones: None. J.M. Hall: None. X. Huang: None. C.G. Minard: None. S. Dei-Tutu: None. A. Butler: None. K. Harrall: None. M. Tosur: None. M.L. Ferm: Advisory Panel; Ended; Rezolute Inc. A. Siller: None. R.S. Aguirre: Advisory Panel; Ended; Sanofi. Research Support; Current; Sanofi. M.J. Redondo: Advisory Panel; Current; Sanofi. Other - Data Safety Monitoring committee; Current; Lilly. Funding NIH NIDDK (R01 DK124395)
Zitieren
APA
JONES, K., HALL, J. M., HUANG, X., MINARD, C. G., DEI-TUTU, S., BUTLER, A., HARRALL, K., TOSUR, M., FERM, M. L., SILLER, A., AGUIRRE, R. S., & REDONDO, M. J. (2026). 2113-P: Beyond Race and Ethnicity in Pediatric Diabetes: Genetic Ancestry and Social Determinants of Health in Diabetic Ketoacidosis. Diabetes, 75(Supplement_1). https://doi.org/10.2337/db26-2113-p
Vancouver
JONES K, HALL JM, HUANG X, MINARD CG, DEI-TUTU S, BUTLER A, et al. 2113-P: Beyond Race and Ethnicity in Pediatric Diabetes: Genetic Ancestry and Social Determinants of Health in Diabetic Ketoacidosis. Diabetes. 2026;75(Supplement_1). doi:10.2337/db26-2113-p
BibTeX
@article{JONES2026,
author = {JONES, KATHRYN and HALL, JACLYN M. and HUANG, XIAOFAN and MINARD, CHARLES G. and DEI-TUTU, SELORM and BUTLER, ASHLEY and HARRALL, KYLIE and TOSUR, MUSTAFA and FERM, MICHAEL L. and SILLER, ALEJANDRO and AGUIRRE, REBECCA S. and REDONDO, MARIA J.},
title = {2113-P: Beyond Race and Ethnicity in Pediatric Diabetes: Genetic Ancestry and Social Determinants of Health in Diabetic Ketoacidosis},
journal = {Diabetes},
year = {2026},
volume = {75},
number = {Supplement_1},
doi = {10.2337/db26-2113-p}
}
EUVIMED